Zhao J, Meisel J, Guo Y, Nahta R, et al. Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies. Breast Cancer Res Treat 2020 Jul 26. pii: 10.1007/s10549-020-05819.
PMID: 32715443